AMRI to recruit more than 40 full-time chemists to work at Lilly’s Indianapolis headquarters
Albany, NY (November 7, 2011) — AMRI (NASDAQ: AMRI) announced today that, as part of a new collaboration agreement with Eli Lilly and Company, it anticipates hiring more than 40 synthetic chemists by the third quarter of 2012 to support Lilly's drug discovery programs. The chemists will work onsite at Lilly's headquarters in Indianapolis, Indiana, where they will support the medicinal chemistry department. This collaboration will further accelerate Lilly's drug discovery efforts by maximizing real-time exchange of scientific information. AMRI expects to recruit the majority of the synthetic chemists who will be affiliated with this collaboration from Indiana and surrounding states.
The term of the collaboration is six years, extendable by mutual agreement of both parties.I had heard tell of this move, but I did not know that
I've always found Lilly to make interesting choices; it seems like their big employment moves are much less telegraphed and it seems like they've spent the 2003-present years without announcing enormous mergers or enormous layoffs. There was, of course, the Covance deal (so we shouldn't really be surprised when that business model is applied to chemistry...)
In the long run, of course, this is really bad news for synthetic chemists and it's another sign that "sticky wages" aren't a problem for us. Best wishes to us all.